IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q4 2022 Holdings

Filed 2023-02-01 | 5 holdings | $184.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dice Therapeutics IncCOM23345J104$102.7M3,292,87155.7%
Vigil Neuroscience Inc(VIGL)COM92673K108$52.7M4,214,49828.6%
Isoplexis CorpCOM465005106$13.7M8,808,5317.4%
Telesis BIO IncCOM192003101$11.8M9,844,1306.4%
Candel Therapeutics Inc(CADL)COM137404109$3.5M1,935,2151.9%